BRÈVE

sur Onco-Innovations Limited (CVE:ONCO)

Onco-Innovations Welcomes Professor Steven Jones as Senior Scientific Advisor

Onco-Innovations Limited announces the appointment of Professor Steven Jones as Senior Scientific Advisor. As Co-Director of the Genome Sciences Centre and Head of Bioinformatics, Jones is esteemed in genomics and cancer research. He will bolster Onco-Innovations' mission to advance cancer care through AI-powered precision oncology.

Steven Jones has made significant contributions to genomics and cancer research, holding accolades from the Royal Society of Canada and the Canadian Academy of Health Sciences. His role will involve guiding the scientific direction of Onco-Innovations' initiatives, focusing on AI-driven oncology solutions.

Collaborating primarily with Inka Health, Jones is set to enhance the company's AI platform, SynoGraph. Included in his duties are fostering collaborations, contributing to key scientific publications, and engaging in public communication to highlight the impact of Onco-Innovations' technologies.

R. H.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Onco-Innovations Limited